Second, disease-specific initiatives should be removed and funding should be redirected to strengthen health systems, with measurable targets. Third, funds should be shifted from expensive US-based organisations to incountry governments and civil society, saving at least 25% in overhead costs. Fourth, accreditation standards should be set that must be met by ministries and local civil society to receive funds. Finally, federal funding should be consolidated under USAID to eliminate the inefficiencies of interagency turf wars. If effi ciency is what we are after, this is a pivot 1 too long delayed. The world is too complicated for diseas e-specifi c approaches to health, as the ravages of Ebola in weak health systems have shown. A health-system strengthening approach will ensure that, especially in times of austerity, there are local institutions and infrastructure in place to provide care for all. health-system disruption. For example, in Zimbabwe, a voluntary medical male circumcision programme will now serve ten instead of 21 districts. Ambassador Birx, referring to these programme cuts as "effi ciencies", touted that funds will be freed up "for the greatest impact.
3 " Although this might optimise impact in areas of the highest HIV/AIDS burden, medical sites are being triaged, with patients losing services and investments being wasted. Concentration on fewer districts also leads to poaching of health workers from already understaff ed sites elsewhere.
Should HIV control trump the care of other patients? Despite much progress, only about 40% of HIV-infected individuals are receiving treatment. Reaching the remaining patients will cost US$18 billion per year, 2 nearly double the present total HIV funding of $9·6 billion, of which PEPFAR contributes $6·8 billion.
2,4,5 With global funding stagnated, 90-90-90 would require increasing HIV's share of all development assistance for health from 27% to more than 50%.
1,5 The proposed investment in 90-90-90 underscores the inherent flaw of disease-specific initiatives-they ignore the needs of other worldwide fatal diseases.
PEPFAR, launched in 2003 with an expensive vertically-oriented model, is now returning to its narrow HIV focus, despite the success of broader investments such as integrated maternal and child health that have decreased stigma and expanded access to HIV services. Absence of new funding and pursuit of a narrowlydefined, disease-specific agenda is self-defeating, weakening the health system on which even wealthy HIV programmes ultimately depend.
For HIV to be controlled without a shift to a more cost-eff ective healthsystem strengthening model is magical thinking. First, the disease-specific US Global AIDS Ambassador position should be renamed to Global Health Ambassador, and the individual in this role should advocate more funding and the reduction of all diseases. figure 1 and tables 2-4 should have read "Of note, the centiles below 28 weeks (dashed lines) should be interpreted with caution given the small sample size." The appendix has been updated as of March 3, 2016.
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